Magnetar Financial LLC Has $65.15 Million Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Magnetar Financial LLC increased its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 19.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 708,732 shares of the medical device company’s stock after buying an additional 117,720 shares during the quarter. Cooper Companies accounts for 1.5% of Magnetar Financial LLC’s investment portfolio, making the stock its 15th largest holding. Magnetar Financial LLC owned 0.36% of Cooper Companies worth $65,154,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also bought and sold shares of the company. Byrne Asset Management LLC bought a new stake in Cooper Companies during the fourth quarter worth $33,000. OFI Invest Asset Management bought a new position in Cooper Companies in the 4th quarter valued at $34,000. Brown Brothers Harriman & Co. grew its stake in Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after purchasing an additional 275 shares during the period. West Financial Advisors LLC bought a new position in Cooper Companies in the 4th quarter valued at $49,000. Finally, Atala Financial Inc bought a new position in Cooper Companies in the 4th quarter valued at $51,000. Institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Friday, March 7th. Piper Sandler restated an “overweight” rating and issued a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. BNP Paribas raised Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. Finally, Robert W. Baird dropped their price target on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a research report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $110.25.

Cooper Companies Stock Up 0.1 %

Shares of NASDAQ COO opened at $80.12 on Thursday. The business’s fifty day moving average price is $90.45 and its 200-day moving average price is $98.44. The stock has a market capitalization of $16.02 billion, a PE ratio of 41.09, a P/E/G ratio of 2.25 and a beta of 1.02. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a one year low of $77.05 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.92. The business had revenue of $964.70 million for the quarter, compared to analysts’ expectations of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.